Revolutionizing Medical Ai Development: Flywheel Announces $54 Million In Series D Funding Led By Novalis Lifesciences And Nventures
Revolutionizing Medical Ai Development: Flywheel Announces $54 Million In Series D Funding Led By Novalis Lifesciences And Nventures
06/27/23, 11:58 AM
Location
minneapolisMoney raised
$54 million
Industry
information technology
Investors
Nvidia, Faegre Drinker Biddle & Reath Llp, Great North Ventures, Seraph, Gundersen Health System, I Select, Intuitive Ventures, Hewlett Packard Enterprise, Beringea, 8 Vc, Invenshure, Microsoft, N Ventures, Novalis Life Sciences Llc
Flywheel, the leading medical imaging data and AI platform, announces it has raised $54 million in Series D funding with more to come soon. This latest round of funding was co-led by Novalis LifeSciences LLC and NVentures, NVIDIA’s venture capital arm. Microsoft also participated in the round, along with insiders Invenshure, 8VC, Beringea, Hewlett Packard Enterprise, Intuitive Ventures, iSelect, Gundersen Health System, Seraph, and Great North Ventures. Faegre Drinker Biddle & Reath LLP served as counsel to Flywheel in connection with the financing.
Company Info
Location
1015 glenwood avenue
minneapolis, minnesota, united states
Additional Info
Flywheel is the pioneering medical imaging data and AI platform powering healthcare innovation through streamlined data aggregation, curation and management. By leveraging cloud scalability and automating workflows, Flywheel helps organizations turn complex imaging data into analysis-ready datasets for accelerated research and AI development. Flywheel offers comprehensive solutions for pharma companies, providers, payors, system integrators, AI developers and academic medical centers.